Royalty Pharma RPRX
NASDAQ RPRX
$57.92 -0.31 (-0.52%)
As of: Sep 30, 2026 · 10:25 AM EDT

Royalty Pharma (RPRX) EBIT Margin (2019 - 2026)

Updated

Royalty Pharma (RPRX) posted EBIT Margin of 19.75% for Q2 2026, down 16.51 percentage points from 36.26% a year earlier and down 69.54 percentage points from the prior quarter.

Analysis

Royalty Pharma (RPRX) EBIT Margin (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Royalty Pharma was 59.61%, down 20.23 percentage points year-over-year; for FY2025, it came in at 65.58%, up 8.48 percentage points from FY2024.

  • Annual EBIT Margin shows a five-year change of -9.60 percentage points (FY2020 to FY2025).
  • In prior years, Royalty Pharma's EBIT Margin was 57.10% in FY2024 (-6.28 pp), 63.37% in FY2023 (+49.65 pp), 13.73% in FY2022 (-48.77 pp) and 62.49% in FY2021 (-12.68 pp).
  • The Q2 2026 figure stands as the lowest quarterly EBIT Margin since Q1 2024.
  • On a year-over-year basis, EBIT Margin increased in three of the last eight quarters, with an average year-over-year change of +9.17 percentage points.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2023, with a gain of 188.14 percentage points; the weakest was Q4 2022, with a drop of 111.96 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was 89.29% (Q1 2026), 62.44% (Q4 2025) and 70.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Orix 43.85 Bn 44.35 Bn - 15.28%
2 Rocket Companies 43.67 Bn 29.35 Bn - 23.53%
3 Royalty Pharma 33.56 Bn 33.48 Bn - 19.75%
4 Federal National Mortgage Association Fannie Mae 25.52 Bn 25.52 Bn - 507.88%
5 Synchrony Financial 23.24 Bn -44.73 Bn - 45.54%
6 Affirm Holdings 22.66 Bn 16.35 Bn - 12.63%
7 Royal Gold 20.35 Bn 19.57 Bn 390.45 Mn 62.13%
8 Annaly Capital Management 15.27 Bn 6.37 Bn - -
9 Ares Capital 13.74 Bn 11.17 Bn - -
10 Federal Home Loan Mortgage 12.68 Bn -6.06 Bn - 551.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.75%
Mar 31, 2026 89.29%
Dec 31, 2025 62.44%
Sep 30, 2025 70.11%
Jun 30, 2025 36.26%
Mar 31, 2025 94.01%
Dec 31, 2024 60.90%
Sep 30, 2024 130.17%
Jun 30, 2024 50.19%
Mar 31, 2024 -12.99%
Dec 31, 2023 102.82%
Sep 30, 2023 28.24%
Jun 30, 2023 46.24%
Mar 31, 2023 70.03%
Dec 31, 2022 -85.31%
Sep 30, 2022 33.52%
Jun 30, 2022 70.49%
Mar 31, 2022 39.09%
Dec 31, 2021 26.65%
Sep 30, 2021 51.74%
API Access

Royalty Pharma EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=RPRX&period=max&api_key=YOUR_API_KEY